6-K ·Filed Aug 20, 2026
Notable filing: 6-K
Actionable Insight • Neutral
This is a routine scheduling notice. Monitor the August 27 earnings release for actual financial results and guidance. No tradeable signal here.
Latest settled — T+20d
CUVL ▼ -24.36% at T+20d
NEUTRAL call -24.36% · α vs SPY -24.36% · entry $7.80 → $5.90
Latest observation: T+45 -42.52% FF3 residual α
T+1d
0.00%
call 0.00% · α -0.41%
$7.80
settled 2mo ago
T+5d
-13.21%
call -13.21% · α -14.32%
$6.77
settled 2mo ago
T+20d
-24.36%
call -24.36% · α -24.36%
$5.90
settled 6w ago
T+60d
Pending
in 16d
Price Chart
Loading chart...
Executive Summary
Clinuvel Pharmaceuticals filed a 6-K announcing that it will release its FY2026 annual results on August 27, 2026, and host an investor webinar. This is a routine scheduling notice with no financial data, guidance, or material business updates. The filing has no immediate trading implications.
Key Facts
- Clinuvel will announce FY2026 annual results on August 27, 2026.
- An investor and analyst webinar is scheduled for 18:00 AEST on August 27, 2026.
- No financial results, guidance, or material business updates were disclosed in this filing.
Financial Impact
No financial data provided in this filing.
Risk Factors
- No financial data disclosed; results could surprise positively or negatively on August 27.
- Forward-looking statements in the filing carry standard biotech risks including regulatory, commercial, and manufacturing uncertainties.
Market Snapshot
Exchange
OTC
Analyst Consensus
91% bullish (11 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-039339 |
| Document: form6-k.htm | 0001493152-26-039339 |
| Document: 0001493152-26-039339-index-headers.html | 0001493152-26-039339 |
| Document: 0001493152-26-039339-index.html | 0001493152-26-039339 |
| Document: 0001493152-26-039339.txt | 0001493152-26-039339 |
8 reports for CUVL
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | 6-K | $5.06 | awaiting T+20 | — | $5.02 (−0.79%) |
Oct 7, 2026 20d ago | 6-K | $5.80 | awaiting T+20 | — | $5.02 (−13.45%) |
Oct 2, 2026 25d ago | 6-K | $6.03 | awaiting T+20 | — | $5.02 (−16.75%) |
Oct 1, 2026 26d ago | 6-K | $5.66 | awaiting T+20 | — | $5.02 (−11.31%) |
Aug 27, 2026 8w ago | 6-K | $6.77 $5.78 | ▼ −14.62% | ▼ −14.12% | $5.02 (−25.85%) |
Aug 27, 2026 8w ago | Press Release | $6.77 $5.78 | ▼ −14.62% | ▼ −14.12% | $5.02 (−25.85%) |
Aug 20, 2026 9w ago | 6-K | $7.80 $5.90 | ▼ −24.36% | ▼ −24.36% | $5.02 (−35.64%) |
Jul 23, 2026 13w ago | 6-K | $6.95 $7.80 | ▲ +12.23% | ▲ +8.92% | $5.02 (−27.77%) |
Showing 8 of 8
US Market Status
Market Closed — Opens Thu (11h 54m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers